2015 Pinnacle Awardee
Vice Chairman of Investment Banking and Managing Director, Mergers & Acquisitions Morgan Stanley
Susie Huang is a Vice Chairman of Investment Banking and a Managing Director in the Mergers & Acquisitions Department at Morgan Stanley, based in New York.
Ms. Huang was a Financial Analyst at Morgan Stanley from 1984-86 and rejoined in 1990 as an Associate, both in the M&A Department. She worked in the Firm’s Hong Kong office in 1993-94, was named a Vice President in 1994, Principal in 1996 and Managing Director in 1999. She has worked on a number of notable transactions, including: the sale of Cubist to Merck; the sale of Taminc to Eastman Chemical; the sale of Wyeth to Pfizer; the sale of Pharmasset to Gilead, P&G’s RMT/split-off of Folgers with Smuckers and its sale of Pringles, GlaxoSmithKline’s acquisition of Human Genome Sciences, Shire’s acquisition of Viropharma, Alkemes’ acquisition of Elan Drug Technologies, the sale of Chattem to sanofi-aventis, Philips’ acquisition of Respironics, Reckitt Benckiser’s acquisition of Schiff Nutrition, and BP’s sale of Innovene. She chairs the Firm’s Executive Women’s Conference for Morgan Stanley’s senior women and clients.
Ms. Huang serves on the Board of Visitors for the John Sloan Dickey Center at Dartmouth College and on the Business Committee of the Metropolitan Museum of Art.
Ms. Huang earned an AB in History from Dartmouth College and a JD and MBA from Columbia University.